ArticleArchives of orthopaedic and trauma surgery2026
Is biceps augmentation effective for scope-assisted lower trapezius tendon transfer in posterosuperior irreparable rotator cuff tears? A retrospective short-term clinical comparison.
Article in Archives of orthopaedic and trauma surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionAlthough favorable clinical outcomes of scope-assisted lower trapezius tendon transfer (SALTT) have been reported in posterosuperior irreparable rotator cuff tears (PSIRCTs) patients, the limited restoring of static stability can be supported by biceps augmentation as a static stabilizer. This study aimed to compare the outcomes of scope-assisted lower trapezius tendon transfer (SALTT) with and without biceps augmentation in patients with posterosuperior irreparable rotator cuff tears (PSIRCTs). MATERIAL AND
methodsThis retrospective clinical comparative study was performed with the inclusion criteria: patients who underwent SALTT for PSIRCT from January 2022 to April 2023; a follow-up period of more than 2 years; and availability for clinical assessment and MRI evaluation preoperatively and at 2 years postoperatively. The patients were grouped according to the management of biceps; Non-augmentation group (n = 26) and Augmentation group (n = 27). The clinical outcomes were evaluated using shoulder pain, patient-reported outcome measures (PROMs), and active range of motion (aROM). Radiological outcomes were performed to evaluate the progression of shoulder joint arthritis, biceps integrity, and graft integrity.
resultsBoth groups showed significant improvements in VAS score, PROMs, and aROM. Although postoperative PROMs of Non-augmentation group were significantly higher than Augmentation group, there was no significant difference in achievement of minimal clinically important difference. The postoperative abduction (p = 0.006) and external rotation (p = 0.024) of Non-augmentation group were significantly higher than Augmentation group. Although the rate of transferred graft rupture was higher in Augmentation group, there was no significant difference between the two groups. However, the rate of biceps rupture of Augmentation group was significantly higher than Non-augmentation group (p = 0.019).
conclusionBiceps augmentation did not yield significant improvements in clinical or radiologic outcomes in SALTT for PSIRCTs. Moreover, it may be associated with increased rates of biceps rupture. LEVEL OF EVIDENCE: Level III.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.